FTC goes after drug middlemen for allegedly jacking up insulin prices

The Big Three handle at least 80% of the country’s insulin prescriptions.

The price of insulin has exponentially increased in recent years. Now, the Federal Trade Commission (FTC) is suing three companies over allegedly inflating the cost of the drug at the expense of Americans who rely on it.

 •  0 comments  •  flag
Share on Twitter
Published on September 20, 2024 20:17
No comments have been added yet.


David Lidsky's Blog

David Lidsky
David Lidsky isn't a Goodreads Author (yet), but they do have a blog, so here are some recent posts imported from their feed.
Follow David Lidsky's blog with rss.